Skip to content
American Academy of Audiology
  • PRACTICE RESOURCES
    • Practice Guidelines and Standards
    • Coding
    • Medicare/Medicaid
    • Compliance
    • Quality Payment Program
  • EDUCATION & EVENTS
    • Event Calendar
    • Continuing Education
    • Online Learning and Certificate Programs
    • Research Grants and Scholarships
    • Faculty and Preceptor Resources
  • AAA ANNUAL CONFERENCE
    • Attend
    • Program and Events
    • Exhibit Hall
    • Exhibit and Sponsorship Opportunities
    • About
  • NEWS & PUBLICATIONS
    • News
    • Audiology Today
    • Journal of the American Academy of Audiology
    • Advertising
    • Permissions and Reprints
    • Press and Media Information
  • CAREERS
    • Career Center
    • Certification
    • Become an Audiologist
    • Doctoral Programs in Audiology
    • Recruiting
    • New Professional Toolkit
  • ADVOCACY
    • Legislative and Regulatory Activities
      • State Affairs
      • Federal Affairs
    • Legislative Action Center
    • Government Relations News
  • CONSUMERS
    • What Is an Audiologist
    • Hearing and Balance Symptoms and Conditions
    • Managing Hearing Loss
    • Seniors and Hearing Loss
    • Children and Hearing Loss
    • OTC Hearing Aid
  • ABOUT THE ACADEMY
    • Leadership
    • Committees and Task Forces
    • Get Involved
    • Honors and Awards
    • Sponsorships and Corporate Partners
    • Contact Us
  • MEMBERSHIP
    • Benefits
    • Ethics
    • Member Directory
    • Membership Renewals
FacebookTwitterLinkedinYoutubeInstagram
  • Students
  • Get Involved
  • Donate
  • Renew
American Academy of Audiology
Member Login
  • PRACTICE RESOURCES
    • Practice Guidelines and Standards
    • Coding
    • Medicare/Medicaid
    • Compliance
    • Quality Payment Program
  • EDUCATION & EVENTS
    • Event Calendar
    • Continuing Education
    • Online Learning and Certificate Programs
    • Research Grants and Scholarships
    • Faculty and Preceptor Resources
  • AAA ANNUAL CONFERENCE
    • Attend
    • Program and Events
    • Exhibit Hall
    • Exhibit and Sponsorship Opportunities
    • About
  • NEWS & PUBLICATIONS
    • News
    • Audiology Today
    • Journal of the American Academy of Audiology
    • Advertising
    • Permissions and Reprints
    • Press and Media Information
  • CAREERS
    • Career Center
    • Certification
    • Become an Audiologist
    • Doctoral Programs in Audiology
    • Recruiting
    • New Professional Toolkit
  • ADVOCACY
    • Legislative and Regulatory Activities
      • State Affairs
      • Federal Affairs
    • Legislative Action Center
    • Government Relations News
  • CONSUMERS
    • What Is an Audiologist
    • Hearing and Balance Symptoms and Conditions
    • Managing Hearing Loss
    • Seniors and Hearing Loss
    • Children and Hearing Loss
    • OTC Hearing Aid
  • ABOUT THE ACADEMY
    • Leadership
    • Committees and Task Forces
    • Get Involved
    • Honors and Awards
    • Sponsorships and Corporate Partners
    • Contact Us
  • MEMBERSHIP
    • Benefits
    • Ethics
    • Member Directory
    • Membership Renewals
May 20, 2020

Ototoxicity of FDA-Approved Drugs Being Re-Purposed for COVID-19 Treatment

  • Audiology in the News

According to the National Institutes of Health’s Center National Center for Advancing Translational Sciences, many drugs approved for other uses already have been tested in humans, so detailed information is available on their pharmacology, formulation, and potential toxicity.

Therefore, trying a Food and Drug Administration (FDA)-approved drug for one disease as a new therapy for an unrelated disease could allow the treatment to be ready for clinical trials more quickly thus speeding the FDA’s review and, if approved, its integration into health care.1 This is more commonly referred to as “drug re-purposing” or “off-label use.”

FDA approval on a repurposed drug can take approximately three to four years as compared to an investigational new drug (IND), which may take greater than 10 years. The approval rate for a repurposed drug in approximately 30 percent1 whereas an IND is less than 12 percent.2

In an effort to combat the coronavirus (COVID-19), front-line physicians have already repurposed two drugs: hydroxychloroquine (brand name Plaquenil®—commonly used for malaria and rheumatoid arthritis) and azithromycin (multiple brand names including Zithromax® Zithromax Tri-Pak®, Azythromycin Dose Pack®, Zithromax Z-Pak® and Zmax®)—a macrolide antibiotic used to treat common infections of the respiratory system, the ear and the eye.

Both drugs are known to be low-risk ototoxic agents; however, there is no published research about the synergistic ototoxic effects of these drugs in treating COVID-19. At the present time, it is not known if hearing loss and/or tinnitus will be a late onset of this COVID-19 drug intervention. Therefore, case history questions will need to be added to accommodate this new population of patients.

Read the full article online.

Share this

Related Posts

‘Eye’ on Health: AI Detects Dizziness and Balance Disorders Remotely

Rizatriptan vs. Placebo for Attacks of Vestibular Migraine: A Randomized Clinical Trial

Use of Medications for Depression by Adults in the United States

Recent Posts

Audiology in the News

‘Eye’ on Health: AI Detects Dizziness and Balance Disorders Remotely

Interesting research led by audiologist Ali Danesh, PhD, at Florida Atlantic University (FAU) helped develop a novel, proof-of-concept tool to help identify nystagmus using a…

Read More
Audiology in the News

Rizatriptan vs. Placebo for Attacks of Vestibular Migraine: A Randomized Clinical Trial

Jeffrey Staab, MD, and colleagues studied the effectiveness of rizatriptan as a treatment option for vestibular migraine. Their research included 134 patients between the ages of…

Read More
message alert on mobile phone screen in a person's hand.
Coding and Reimbursement

CMS Warns of Fraud Scheme

The Centers for Medicare and Medicaid Services (CMS) is warning providers to be on alert for phishing requests to provide Medicare patient information. CMS has…

Read More
wave-mark

Join the Academy

Academy members receive many benefits for professional development, practice management, and community development.

Become a Member
COMM24-Academy_Website_Graphics-revised_logo(W)

American Academy of Audiology
11480 Commerce Park Drive
Suite 220
Reston, VA 20191

Tel: 703-790-8466
Fax: 703-790-8631

  • Practice Resources
  • Education and Events
  • AAA Annual Conference
  • News and Publications
  • Careers
  • Advocacy
  • About the Academy
  • Consumers and Patients
  • Students
  • Donate
  • Get Involved
  • Contact Us
  • Privacy Policy
  • Antitrust Policy and Guidelines
  • Terms of Use Policy
  • Accessibility Statement
  • Sitemap

© Copyright 2025 American Academy of Audiology

Website by Yoko Co

This content is an exclusive benefit for American Academy of Audiology members.

If you’re a member, log in and you’ll get immediate access.

 

Member Login

 

If you’re not yet a member, you’ll be interested to know that joining not only gives you access to top-notch resources like this one, but also invitations to member-only events, inclusion in the member directory, participation in professional forums, and access to patient resources, tools, and continuing education. Join today!

Scroll To Top
We use cookies to improve your experience on our site. By continuing to use our site, you accept our use of cookies. To learn more, please see our Privacy Policy.Ok